Background. To assess the frequency and characteristics of cardiac arrhythmias in relation to cardiac remodeling and blood prolactin levels in patients with peripartum cardiomyopathy (PPCM). Materials and methods. The study included 104 patients with a confirmed diagnosis of PPCM, classified according to the 1995 WHO guidelines and recommendations from the 2010 Working Group on Peripartum Cardiomyopathy, Association of Heart Failure, EOC. All patients received optimized pharmacological therapy for heart failure (HF). Patients were divided into two groups based on prolactin levels: Group I included 30 patients with elevated prolactin levels exceeding 496 uU/ml (mean 612.2±65.9 uU/ml), and Group II comprised 74 patients with normal prolactin levels below 496 uU/ml (mean 236.3±75.9 uU/ml). Blood samples for prolactin were collected during the manifestation of clinical HF symptoms, from initial inpatient admission up to the 3rd-4th month postpartum. Results. Comparative analysis revealed that the total number of left ventricular rhythm disturbances (LVRS) was similar across groups, averaging 456.9±215.89 per day in Group I and 398.69±315.89 in Group II (p>0.05). Both groups exhibited a higher prevalence of ventricular ectopic activity during the daytime, with a day/night ratio of 1.34±0.3 in Group I and 1.5±0.44 in Group II (p>0.05). Conclusion. The findings indicate that patients with PPCM and elevated blood prolactin levels experience significantly more frequent and complex ventricular extrasystole, which could have predictive implications for patient prognosis. Further research is needed to explore the prognostic value of prolactin levels in managing ventricular arrhythmias in PPCM patients.
| Mualliflar | Худойберганов, О, Абдуллаев , Т, Цой , И, Мирзарахимова , С, Пазилжанов , Н, Khudoyberganov , Otabek, Abdullaev , Timur, Tsoi , Igor, Mirzarakhimova, Saodat, Pazylzhanov , Nematillo, Khudoyberganov, Otabek, Abdullaev , Timur, Tsoi , Igor, Mirzarakhimova, Saodat, Pazylzhanov , Nematillo |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-03-30 |
| Jild | 1 |
| Son | 1 |
| Betlar | 14-21 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00002 |
DOI: 10.70626/cardiouz-2024-1-00002 · Maqolaning asl sahifasi
peripartum cardiomyopathy, ventricular arrhythmias, prolactin levels, cardiac remodeling, heart failure, prognostic indicators, maternal health, перипартальная кардиомиопатия, желудочковые аритмии, уровень про- лактина, ремоделирование сердца, сердечная недостаточность, прогностические показатели, здоровье матери, Peripartal kardiomiopatiya, ventrikulyar aritmiyalar, prolaktin darajasi, yurakni qayta qurish, yurak yetishmovchiligi, prognoz ko'rsatkichlari, ona salomatligi
Background. Contrast-induced nephropathy (CIN) is a common complication among patients with ischemic heart disease (IHD) undergoing percutaneous coronary intervention (PCI). Understanding the pathogenesis, risk factors…
Background. The 2023 ESC guidelines on cardiomyopathies introduce significant updates in diagnostic criteria, terminology, and treatment protocols. These guidelines aim to provide comprehensive approaches for diagnosis…
Background. This study explores the impact of anxiety and depressive disorders on the rehabilitation outcomes and long-term prognosis of patients with acute myocardial infarction (AMI) and unstable angina. The aim is to…
Background. Atherosclerosis is a leading cause of cardiovascular mortality worldwide, significantly impacting public health. microRNA, as key regulators of gene expression, play a crucial role in the pathogenesis of…
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…
Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased…
Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and…
The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic…
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations…
Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors…